Foghorn Therapeutics Inc.

FHTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.25

+$0.10 (+2.41%)

Sep 22, 2026, 12:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-74.28M	-86.62M	-98.43M	-108.88M	-101.32M	-68.8M
Depreciation & Amortization	3.33M	3.12M	3.45M	7.9M	3.23M	1.33M
Stock-Based Compensation	10.4M	11.89M	16.19M	n/a	8.38M	2.96M
Other Working Capital	-32.62M	-29.79M	-42.73M	-20.07M	336.48M	28.23M
Other Non-Cash Items	6.59M	3.47M	2.56M	13.05M	4.61M	4.44M
Deferred Income Tax	n/a	n/a	n/a	n/a	1.41M	84K
Change in Working Capital	-32.14M	-32.27M	-41.88M	281.55M	33.44M	28.7M
Operating Cash Flow	-86.1M	-100.41M	-118.11M	193.61M	-50.25M	-31.29M
Capital Expenditures	-50K	-906K	-1.22M	-1.21M	-3.31M	-16.18M
Cash Acquisitions	n/a	n/a	n/a	n/a	-39.49M	250K
Purchase of Investments	-131.25M	-261.47M	-73.9M	-409.35M	-99.98M	-92.98M
Sales Maturities Of Investments	243.34M	232.47M	219.58M	166.23M	139.47M	-250K
Other Investing Acitivies	n/a	n/a	n/a	n/a	39.49M	250K
Investing Cash Flow	112.04M	-29.9M	144.45M	-244.32M	36.17M	-108.91M
Debt Repayment	n/a	n/a	n/a	n/a	-21.21M	4.27M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	2.03M	1.78M	n/a	1.42M	1.22M
Financial Cash Flow	1.02M	105.43M	1.78M	1.76M	22.42M	217.47M
Net Cash Flow	26.96M	-24.88M	28.12M	-48.92M	8.34M	77.27M
Free Cash Flow	-86.15M	-101.31M	-119.33M	192.4M	-53.56M	-47.47M
Adj. Free Cash Flow	-96.55M	-113.21M	-135.52M	192.4M	-61.95M	-50.43M
Maintenance CapEx	n/a	-906K	n/a	n/a	n/a	n/a
Growth CapEx	-50K	n/a	-1.22M	-1.21M	-3.31M	-16.18M
Owner Earnings	-86.1M	-101.31M	-118.11M	193.61M	-50.25M	-31.29M